Cargando…
Quantitative Comparison of HSF1 Activators
The heat shock response (HSR) pathway is a highly conserved rescue mechanism, which protects the cells from harmful insults disturbing the cellular protein homeostasis via expression of chaperones. Furthermore, it was demonstrated to play crucial roles in various diseases like neurodegeneration and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259536/ https://www.ncbi.nlm.nih.gov/pubmed/35218516 http://dx.doi.org/10.1007/s12033-022-00467-3 |
_version_ | 1784741806309638144 |
---|---|
author | Steurer, Christoph Kerschbaum, Sarah Wegrostek, Christina Gabriel, Stefan Hallaj, Ali Ortner, Viktoria Czerny, Thomas Riegel, Elisabeth |
author_facet | Steurer, Christoph Kerschbaum, Sarah Wegrostek, Christina Gabriel, Stefan Hallaj, Ali Ortner, Viktoria Czerny, Thomas Riegel, Elisabeth |
author_sort | Steurer, Christoph |
collection | PubMed |
description | The heat shock response (HSR) pathway is a highly conserved rescue mechanism, which protects the cells from harmful insults disturbing the cellular protein homeostasis via expression of chaperones. Furthermore, it was demonstrated to play crucial roles in various diseases like neurodegeneration and cancer. For neurodegenerative diseases, an overexpression of chaperones is a potential therapeutic approach to clear the cells from non-functional protein aggregates. Therefore, activators of the HSR pathway and its master regulator HSF1 are under close observation. There are numerous HSR activators published in the literature using different model systems, experimental designs, and readout assays. The aim of this work was to provide a quantitative comparison of a broad range of published activators using a newly developed HSF responsive dual-luciferase cell line. Contrary to natural target genes, which are regulated by multiple input pathways, the artificial reporter exclusively reacts to HSF activity. In addition, the results were compared to endogenous heat shock protein expression. As a result, great differences in the intensity of pathway activation were observed. In addition, a parallel viability assessment revealed high variability in the specificity of the drugs. Furthermore, the differences seen compared to published data indicate that some activators exhibit tissue-specific differences leading to interesting assumptions about the regulation of HSF1. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12033-022-00467-3. |
format | Online Article Text |
id | pubmed-9259536 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-92595362022-07-08 Quantitative Comparison of HSF1 Activators Steurer, Christoph Kerschbaum, Sarah Wegrostek, Christina Gabriel, Stefan Hallaj, Ali Ortner, Viktoria Czerny, Thomas Riegel, Elisabeth Mol Biotechnol Original Paper The heat shock response (HSR) pathway is a highly conserved rescue mechanism, which protects the cells from harmful insults disturbing the cellular protein homeostasis via expression of chaperones. Furthermore, it was demonstrated to play crucial roles in various diseases like neurodegeneration and cancer. For neurodegenerative diseases, an overexpression of chaperones is a potential therapeutic approach to clear the cells from non-functional protein aggregates. Therefore, activators of the HSR pathway and its master regulator HSF1 are under close observation. There are numerous HSR activators published in the literature using different model systems, experimental designs, and readout assays. The aim of this work was to provide a quantitative comparison of a broad range of published activators using a newly developed HSF responsive dual-luciferase cell line. Contrary to natural target genes, which are regulated by multiple input pathways, the artificial reporter exclusively reacts to HSF activity. In addition, the results were compared to endogenous heat shock protein expression. As a result, great differences in the intensity of pathway activation were observed. In addition, a parallel viability assessment revealed high variability in the specificity of the drugs. Furthermore, the differences seen compared to published data indicate that some activators exhibit tissue-specific differences leading to interesting assumptions about the regulation of HSF1. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12033-022-00467-3. Springer US 2022-02-26 2022 /pmc/articles/PMC9259536/ /pubmed/35218516 http://dx.doi.org/10.1007/s12033-022-00467-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Steurer, Christoph Kerschbaum, Sarah Wegrostek, Christina Gabriel, Stefan Hallaj, Ali Ortner, Viktoria Czerny, Thomas Riegel, Elisabeth Quantitative Comparison of HSF1 Activators |
title | Quantitative Comparison of HSF1 Activators |
title_full | Quantitative Comparison of HSF1 Activators |
title_fullStr | Quantitative Comparison of HSF1 Activators |
title_full_unstemmed | Quantitative Comparison of HSF1 Activators |
title_short | Quantitative Comparison of HSF1 Activators |
title_sort | quantitative comparison of hsf1 activators |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259536/ https://www.ncbi.nlm.nih.gov/pubmed/35218516 http://dx.doi.org/10.1007/s12033-022-00467-3 |
work_keys_str_mv | AT steurerchristoph quantitativecomparisonofhsf1activators AT kerschbaumsarah quantitativecomparisonofhsf1activators AT wegrostekchristina quantitativecomparisonofhsf1activators AT gabrielstefan quantitativecomparisonofhsf1activators AT hallajali quantitativecomparisonofhsf1activators AT ortnerviktoria quantitativecomparisonofhsf1activators AT czernythomas quantitativecomparisonofhsf1activators AT riegelelisabeth quantitativecomparisonofhsf1activators |